A simple, rapid immunometric assay for determination of functional and growth hormone-occupied growth hormone-binding protein in human serum

被引:66
作者
Fisker, S
Frystyk, J
Skriver, L
Vestbo, E
Ho, KKY
Orskov, H
机构
[1] AARHUS UNIV HOSP, DEPT ENDOCRINOL & DIABET, DK-8000 AARHUS, DENMARK
[2] AARHUS UNIV HOSP, INST EXPT CLIN RES, DK-8000 AARHUS, DENMARK
[3] NOVO NORDISK AS, BIOPHARMACEUT DIV, DK-2820 GENTOFTE, DENMARK
[4] ST VINCENTS HOSP, GARVAN INST MED RES, SYDNEY, NSW 2010, AUSTRALIA
关键词
acromegalic; complexed growth hormone-binding protein; growth hormone; growth hormone-binding protein; growth hormone deficient; somatotropin;
D O I
10.1046/j.1365-2362.1996.2010558.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We present a sensitive time-resolved fluorometric immunofunctional assay (TR-FIA) for direct quantitation of functional growth hormone-binding protein (GHBP), using an immunoassay kit for growth hormone (GH-DELFIA). In addition to the immobilized GH antibody, one monoclonal antibody against GHBP was used. This anti-GHBP was labelled with the chelate of europium. The assay was performed in one step. The detection limit for GHBP was 0.044 nmol L(-1) (NBS + 3 SD). The calibration curve was linear in the interval 0.11-8.03 nmol L(-1) Average intra-assay coefficient of variation (CV) was 3.44%. Average interassay CV at GHBP concentrations 0.563 nmol L(-1) and 1.40 nmol L(-1) were 12% and 6.3% respectively. Analytical recovery in serum ranged from 76% to 127% with a mean of 101 +/- 3.6%. Serum GHBP in 102 normal subjects ranged from 0.513 to 3.772 nmol L(1) and was positively related to body mass index (P < 0.001). In growth hormone-deficient sera GHBP was higher than in control subjects (1.751 +/- 0.179 nmol L(-1) and 1.257 +/- 0.140 nmol L(-1) respectively, P < 0.001). Acromegalic patients had lower levels of GHBP than controls (0.946 +/- 0.251 and 1.234 +/- 0.144 nmol L(-1) respectively, P = 0.005). This assay also allowed detection of GH-complexed GHBP in serum. These results were in agreement with theoretical values calculated from the measured GH and the functional GHBP concentrations. Results were compared with data obtained by a recently reported, validated ligand immunofunctional assay (LIFA), which is fundamentally different. There was a significant linear relationship between the results from the two assays (r = 0.89, P = 0.001). The slope of the regression line was 0.65. In conclusion, this new convenient GHBP TR-FIA provides a sensitive and precise method for detecting total GHBP as well as complexed GHBP in human serum, and allows easy processing of large numbers of samples.
引用
收藏
页码:779 / 785
页数:7
相关论文
共 34 条
  • [1] SIMPLE ALGEBRAIC AND GRAPHIC METHODS FOR THE APPORTIONMENT OF HORMONE (AND RECEPTOR) INTO BOUND AND FREE FRACTIONS IN BINDING EQUILIBRIA - OR HOW TO CALCULATE BOUND AND FREE HORMONE
    BARSANO, CP
    BAUMANN, G
    [J]. ENDOCRINOLOGY, 1989, 124 (03) : 1101 - 1106
  • [2] A SPECIFIC GROWTH HORMONE-BINDING PROTEIN IN HUMAN-PLASMA - INITIAL CHARACTERIZATION
    BAUMANN, G
    STOLAR, MW
    AMBURN, K
    BARSANO, CP
    DEVRIES, BC
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (01) : 134 - 141
  • [3] REGULATION OF PLASMA GROWTH HORMONE-BINDING PROTEINS IN HEALTH AND DISEASE
    BAUMANN, G
    SHAW, MA
    AMBURN, K
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1989, 38 (07): : 683 - 689
  • [4] THE CIRCULATING GROWTH-HORMONE (GH)-BINDING PROTEIN COMPLEX - A MAJOR CONSTITUENT OF PLASMA GH IN MAN
    BAUMANN, G
    AMBURN, K
    SHAW, MA
    [J]. ENDOCRINOLOGY, 1988, 122 (03) : 976 - 984
  • [5] GROWTH-HORMONE INSENSITIVITY ASSOCIATED WITH ELEVATED CIRCULATING GROWTH HORMONE-BINDING PROTEIN IN CHILDREN WITH ALAGILLE SYNDROME AND SHORT STATURE
    BUCUVALAS, JC
    HORN, JA
    CARLSSON, L
    BALISTRERI, WF
    CHERNAUSEK, SD
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1993, 76 (06) : 1477 - 1482
  • [6] REDUCED CONCENTRATION OF SERUM GROWTH HORMONE-BINDING PROTEIN IN CHILDREN WITH IDIOPATHIC SHORT STATURE
    CARLSSON, LMS
    ATTIE, KM
    COMPTON, PG
    VITANGCOL, RV
    MERIMEE, TJ
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 78 (06) : 1325 - 1330
  • [7] LIGAND-MEDIATED IMMUNOFUNCTIONAL ASSAY FOR QUANTITATION OF GROWTH HORMONE-BINDING PROTEIN IN HUMAN BLOOD
    CARLSSON, LMS
    ROWLAND, AM
    CLARK, RG
    GESUNDHEIT, N
    WONG, WLT
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (06) : 1216 - 1223
  • [8] SUPPLEMENTAL GROWTH-HORMONE INCREASES THE TUMOR CYTOTOXIC ACTIVITY OF NATURAL-KILLER-CELLS IN HEALTHY-ADULTS WITH NORMAL GROWTH-HORMONE SECRETION
    CRIST, DM
    KRANER, JC
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1990, 39 (12): : 1320 - 1324
  • [9] INHIBITION OF GROWTH-HORMONE BIOACTIVITY BY RECOMBINANT HUMAN GROWTH HORMONE-BINDING PROTEIN IN THE ELUTED STAIN ASSAY SYSTEM
    DATTANI, MT
    HINDMARSH, PC
    BROOK, CGD
    ROBINSON, ICAF
    MARSHALL, NJ
    [J]. JOURNAL OF ENDOCRINOLOGY, 1994, 140 (03) : 445 - 453
  • [10] SERUM GROWTH HORMONE-BINDING PROTEIN IS UNCHANGED IN ADULT PANHYPOPITUITARISM
    DAVILA, N
    ALCANIZ, J
    SALTO, L
    ESTRADA, J
    BARCELO, B
    BAUMANN, G
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (05) : 1347 - 1350